Biopool raises finance for serology purchase:
This article was originally published in Clinica
Diagnostics company Biopool has paid $4.5 million in cash for the blood group serology business it acquired from Dutch company Organon Teknika last year (see Clinica No 731, p 11). To finance some of this amount, Biopool sold 500,000 shares at $2.19 each in a private placement in December. The rest was raised as a loan.